GLP-1 Tirzepatide
Tirzepatide Research Peptide in Canada
Precision Synthetics Canada supplies Tirzepatide (LY3298176) as a lyophilized powder in sealed 3 mL glass vials for qualified laboratory and analytical research. Orders ship from Vancouver to Canadian addresses, and the selector on this page shows the current vial sizes, prices and stock.
Tirzepatide is studied as a dual receptor agonist across the GIP (GIPR) and GLP-1 (GLP-1R) pathways. The research material listed here is not a prescription product and is supplied only for laboratory use.
Compound identity and testing
Compound identity
| Compound |
Tirzepatide |
| Development code |
LY3298176 |
| CAS number |
2023788-19-2 |
| Molecular formula |
C225H348N48O68 |
| Appearance |
Lyophilized powder, as recorded on our SideChain Analytics COAs |
| Container |
Sealed 3 mL glass vial |
Reports by vial size
SideChain Analytics is our primary testing laboratory, with occasional supplementary testing by Testides, Vanguard Laboratory and Janoshik. Each report keeps its actual issuing laboratory and reported results.
Match the lot printed on the vial to its report through the Product COA button on this page or the Certificate of Analysis library.
Research use only. Not for human or veterinary use.
